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ABSTRACT 
 
 
 
 
Orthosiphon stamineus (OS) is a Malaysian medicinal herb that was reported 
to have weight reduction effect and normally prepared as herbal infusion. Effective 
topical utilization of OS requires a good drug delivery system in order to overcome 
the stratum corneum to reach the targeted area. Nanostructured lipid carrier (NLC) is 
a promising carrier for topical drug delivery. The goal of the present study was to 
optimize the formulation of OS-loaded nanostructured lipid carrier (OS-NLC) for 
improved lipolysis activity. OS-NLC was prepared using melt emulsification 
homogenization technique with different types of lipid to obtain good homogeneity 
and miscibility of the formulation. The result revealed the preferred selection of 
glyceryl monostearate as solid lipid and triglyceride as liquid lipid since they showed 
good homogeneity. The formulation of OS-NLC was optimized using D-optimal 
mixture design which consisted of an amount of active ingredients, solid lipid, and 
liquid lipid as independent variables while particle size, polydispersity index (PDI) 
and encapsulation efficiency as dependent variables. From the study, it was found 
that the optimum formulation of OS-NLC was made of 4% OS, 1% glyceryl 
monostearate, and 5% triglyceride with 88.57 ± 1.187 nm particle size, 0.135 ± 0.007 
PDI and 98.10 ± 1.101 % encapsulation efficiency. Coefficient of determination (R2) 
indicated a good fit between predicted values and the experimental data points for 
particle size, PDI and encapsulation efficiency, which were found to be 0.9404, 
0.9138 and 0.8754, respectively. Transmission electron microscopy images exhibited 
the spherical shape of OS-NLC. Fourier transform infrared spectroscopy analysis 
demonstrated an interaction between OS extract and NLC system. The zeta potential 
of OS-NLC was -16.7 ± 0.5033 mV. Storage stability of OS-NLC was conducted at 
cold and room temperature for one month by measuring the particle size, PDI and 
zeta potential. The results revealed that there were no significant changes in particle 
size, PDI and zeta potential within one month. The in vitro penetration study using 
Franz diffusion cell showed that the penetration flux of OS-NLC (2188.74 μg cm-1h-
1) was significantly higher than OS (1614.20 μg cm-1h-1). The result proved that NLC 
encapsulate OS had better delivery system compared to OS extract. In lipolysis study, 
OS-NLC was found to stimulate the release of glycerol in 3T3-L1 adipocytes cells. 
Taken together, the optimal OS-NLC formulation had efficiently enhanced 
penetration into skin and improved the lipolysis activity in adipocyte cell. 
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ABSTRAK 
 
 
 
 
Orthosiphon stamineus (OS) adalah herba perubatan Malaysia yang dilaporkan 
mempunyai kesan penurunan berat badan dan biasanya digunakan sebagai infusi 
herba. Penggunaan berkesan OS memerlukan sistem penghantaran ubat yang baik 
untuk mengatasi lapisan stratum corneum. Pembawa lipid berstruktur nano (NLC) 
adalah pembawa yang berkebolehan untuk penghantaran ubat topikal. Matlamat kajian 
ini adalah untuk mengoptimumkan formulasi OS dimuatkan ke dalam pembawa lipid 
berstruktur nano (OS-NLC) bagi meningkatkan meningkatkan aktiviti lipolisis dalam 
sel lemak. OS-NLC dihasilkan daripada teknik penyeragaman pengemulsian lebur 
dengan menggunakan pelbagai jenis lipid untuk mendapatkan keseragaman dan 
kebolehcampuran formulasi yang baik. Hasil kajian mencadangkan pilihan gliseril 
monostearat sebagai lipid pepejal dan trigliserida sebagai lipid cecair lebih diutamakan 
kerana mereka menunjukkan keseragaman yang baik. Formulasi OS-NLC 
dioptimumkan dengan menggunakan reka bentuk campuran D-optimum yang terdiri 
daripada bahan aktif, lipid pepejal dan lipid cecair sebagai pemboleh ubah tak 
bersandar manakala pemboleh ubah bersandar terdiri daripada saiz partikel, indeks 
kepoliserakan (PDI) dan kecekapan pengkapsulan. Berdasarkan keputusan kajian, 
formulasi optimum OS-NLC terdiri daripada 4% OS, 1% gliseril monostearat, dan 5% 
trigliserida dengan saiz partikel 88.57 ± 1.187 nm, 0.135 ± 0.007 PDI dan 98.10 ± 
1.101% kecekapan enkapsulasi. Pekali penentuan (R2) menunjukkan kesesuaian antara 
nilai ramalan dan data eksperimen untuk saiz partikel, PDI dan kecekapan enkapsulasi 
masing-masing adalah 0.9404, 0.9138 dan 0.8754. Imej mikroskop elektron transmisi 
menunjukkan OS-NLC berbentuk sfera. Spektroskopi inframerah transformasi Fourier 
menunjukkan interaksi antara ekstrak OS dan sistem NLC. Potensi zeta bagi OS-NLC 
ialah -16.7 ± 0.5033 mV. Kestabilan penyimpanan OS-NLC telah dijalankan pada 
suhu sejuk dan bilik selama satu bulan dengan mengukur saiz partikel, PDI dan potensi 
zeta. Hasil kajian mendapati tiada perubahan signifikan dalam saiz partikel, PDI dan 
potentsi zeta dalam masa satu bulan. Kajian penembusan transdermal in vitro 
menggunakan sel penyebaran Franz menunjukkan bahawa fluks penembusan OS-NLC 
(2188.74 μg cm-1h-1) adalah lebih tinggi daripada OS (1614.20 μg cm-1h-1). Hasilnya 
membuktikan bahawa NLC merangkumi OS menunjukkan sistem penghantaran yang 
lebih baik berbanding dengan ekstrak OS. Dalam kajian lipolisis, OS-NLC didapati 
boleh melepaskan gliserol dalam sel adiposit 3T3-L1. Secara keseluruhannya, 
formulasi OS-NLC yang optimum adalah cekap dalam meningkatkan penembusan ke 
dalam kulit dan meningkatkan aktiviti lipolysis dalam sel adiposit.  
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CHAPTER 1 
 
 
 
 
INTRODUCTION 
 
 
 
 
1.1 Background of the Study 
 
 
The largest organ in the human body is the skin. The function of skin is to protect 
the body from any unwanted influences from the environment. The skin consists of the 
epidermis, dermis and hypodermis. Stratum corneum is the outermost layer of the 
human skin. It is known that stratum corneum acts as a skin barrier function. A 
successful transdermal drug delivery must prevail over the stratum corneum.  Thus, 
many approaches have been done to overcome the barrier function and enhance drug 
transport into the skin (Ghafourian et al., 2004) 
 
 
Nanotechnology or nanoparticles used as drug delivery vehicle generally have 
particle size less than 100nm. Nanoparticles are effective transport and delivery system 
since it improve the bioavaibility of drugs and provide the necessary protection of 
drugs molecule. Lipid nanoparticles such liposome, nanoemulsion, microemulsion, 
solid lipid nanoparticles, and nanostructured lipid carrier are gaining a lot of interest 
as a vehicle for controlled released of active substances and targeting to skin layer. In 
the beginning of 1990s, solid lipid nanoparticles (SLN) were developed as a carrier  
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system to substitute emulsion, liposomes and polymeric nanoparticles (Muller et al., 
2002). SLN is produced by solid lipid only.  However, SLN produced a perfect crystal 
lattice which provides limited space to hold the active, hence causes expulsion of 
active from the lipid matrix during storage (Bunjes and Koch, 1996).   
 
 
Nanostructured lipid carrier (NLC) has been introduced to overcome the 
limitation of solid lipid nanoparticles. Components of NLC are solid lipid, liquid lipid, 
surfactants and water. NLC is produced by blending both solid and liquid lipids. The 
combination of solid and liquid lipids alters the formation of perfect crystal thus the 
matrix is in imperfect form and provides space to hold the active in the lipid matrix. In 
view of topical administration, NLC has occlusive properties and can reduce 
transepidermal water loss (TEWL) thus enhance penetration of active ingredient 
through the stratum corneum by increased hydration (Uprit et al., 2013). NLC offers 
potential advantages such as protection of active ingredients against degradation, 
controlled and sustained release of active drug can be achieved, high drug loading 
capacity, and improve skin permeation (Patel et al., 2013).  
 
 
Having an excess body fat will lead to several health risk such as being 
overweight. Adipocytes acts as cells that stored energy as fat. Three different types of 
adipocytes are white adipocytes, brown adipocytes and beige adipocytes. White 
adipocytes are responsible to store energy and brown adipocytes to dissipate energy in 
thermogenesis. While the function of beige adipocytes is still not clear (Stephens, 
2012).  
 
 
Lipolysis is the process of breakdown of triglyceride to free fatty acid and 
glycerol. This process takes place in white adipose tissue. Enzymes are involved in 
lipolysis process are adipose triglyceride lipase (ATGL), hormone sensitive lipase 
(HSL) and monoacylglycerol lipase (MAG) (Zechner et al., 2012). In the first step of 
lipolysis ATGL is responsible to catalyze the conversion of triglyceride into 
diacylglycerol whereas HSL will hydrolyze diacylglycerol to monoacylglycerol and 
MAG hydrolyze monoacylglycerol to glycerol. The main pathway for lipolysis process 
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is through the activation of cAMP dependent protein kinase A (PKA) (Kim et al., 
2014).  
 
 
Orthosiphon stamineus (OS) or commonly known as Misai kucing in malay 
community is a Lamiacae family. OS has been used to treat diabetes, hypertension, 
menstrual disoder, epilepsy and rheumatic arthritis. Three phytochemical compounds 
found in different extract of OS are polymethoxylated flavonoids, phenylpropanoids 
and terpenoids.  Major component of aqueous extract in OS is rosmarinic acid which 
exhibits antioxidant, immunomodulatory and anti-cancer activity (Scheckel et al., 
2008; Yam et al., 2009; Ameer et al., 2012).  Combination of OS powder with green 
tea has been utilized for weight reduction effect (Ameer et al., 2012).  In addition, 
previous study by Son et al., (2011) found OS can reduced visceral fat mass and food 
intake in Sprague-Dawley rats. Study conducted by Sayedan et al. (2016) found that 
the ethanolic extract of OS leaves significantly reduced a gain in body weight which 
give weight reduction effect in obese mice induced by a high fat diet. This conclude 
that OS can be a medicinal food for body weight control. 
 
 
However, most weight reduction drug has been hardly approved by the Food 
and Drug Administration (FDA) authority, as compared with transdermal patches and 
beauty creams. In order to loss fat at specific areas, lipolytic agent such as 
aminophylline and caffeine can be applied to the skin. Aminophylline and caffeine 
were found to liberate subcutaneous fat, thinning the fat layer and also reducing 
cellulite (Caruso et al., 2007). Previous study revealed that external medicinal such as 
topical cream composed of aminophylline possess weight reduction effect (Petrofsky, 
et al., 2014). Therefore, it was highly potential to use OS as a topical drug to induce 
lipolysis in adipocyte which located in subcutaneous layer as well as to achieve 
systemic weight reduction. 
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Formulation of NLC to encapsulate OS is a challenging task due to the trial and 
error which can be time consuming and required high cost. Optimization provide 
significant understanding of develop formulation and their properties can be gained. 
Experimental design plays bigger role in cosmetic formulation because it provides 
better understanding about the effect of different product formulation on product 
properties (Rajin et al., 2007). The desired formulation can be achieved as fast as 
possible with experimental design because it can reduce number of experiments. 
Several statistical designs available such as response surface methodology (RSM), 
factorial design, combined and mixture design. For experiments that have various 
mixed ingredients, mixture design is employ in order to identify ingredients that give 
effect on the dependent variables and also to determine the optimal mixing ratio that 
maximizes or minimizes the dependent variables (Choi, 1998). The D optimal design 
is suitable for highly constraint design and widely used in drug delivery devices (El-
Malah et al., 2006).  
 
 
The present work was aim to produce cost effective of OS-NLC by optimizing 
the formulation using D-optimal mixture design in order to improve skin penetration 
and induce lipolysis activity. 
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1.2 Problem Statement 
 
 
Topical drug delivery (TDD) can be described as the application of a drug 
containing formulation directly to the skin. Once topical formulation was applied to 
the skin, they must interact with the skin condition which can control the rate of release 
of the compound. TDD is favoured due to the ease of delivery and most importantly 
TDD have no intervention with gastric and intestinal fluid (Sharma et al., 2013). 
However, TDD poses a challenge due to the skin barrier. Besides, the protection of 
active ingredient is a crucial factor in TDD to protect the active ingredient from 
degradation and successfully delivered the active ingredient to the targeted area.  
 
 
Nanostructured lipid carriers (NLC) is a lipid based nanoparticles which 
normally have a particle size less than 100 nm. NLC is considered as a novel drug 
delivery system to deliver active ingredients with high solubility, stability, effective 
skin penetration and low irritation. Many studies have found that NLC can increase 
the encapsulation efficiency due to the involvement of two type of lipids in NLC which 
gives the imperfection in their structure thus provide more space to accommodate the 
active ingredient. The addition of liquid lipid is the main factor that contributes higher 
encapsulation efficiency because of the higher solubility of drugs in liquid lipid in 
comparison with solid lipid (Muchow et al., 2008). NLC has the ability to incorporate 
both hydrophilic and lipophilic drugs. Moreover, the main advantage of NLC over 
other delivery system is the protection of active ingredient from degradation. 
 
 
Generally OS has been used as diuretic, to treat rheumatism, kidney and bladder 
inflammation. Most of the compounds found on OS such as terpenoids, polyphenols, 
orthosiphols were found to have weight reduction effect (Jayaprakasam et al., 2006). 
Study by Son et al., (2011) found that the OS can reduce appetite and fat deposition, 
food intake and visceral fat mass in sprague dawley rats which conclude that OS can 
act as medicinal food application for body weight control. Collectively, it is postulated 
that OS may play an important role in the treatment of obesity such as numerous in-
vivo study were conducted by using Sprague dawley rats. However, the ability of OS 
6 
 
to act as anti-obesity medicinal by inducing lipolysis through direct action on adipose 
tissue is still not clear 
 
 
The most effective way to reduce weight is by exercise and healthy diet. However, 
with dieting and exercise it is hard to target where fat loss occurs. Fat loss can occur 
in any area of the body. Therefore, if fat loss is to be targeted at specific areas, lipolytic 
agent can be applied to the skin. In addition, due to the topical administration of drug 
are much safer compared with oral medication, an external topical formulation of OS 
seem to have high potential to be used as a weight reduction treatment. However, the 
poor skin permeation of OS was a challenge to develop OS as transdermal delivery 
system. 
 
 
Therefore, in this study, NLC is chosen as a carrier to deliver the OS to the 
targeted area due to the ability of NLC to encapsulate and protect OS from degradation 
and to overcome the stratum corneum. In addition, this study emphasized the 
production of OS-NLC for cosmeceutical application and reveal that NLC is an 
effective delivery system that enhanced penetration over stratum corneum.  
 
 
1.3 Objective 
 
 
The objective of this research is to optimize the formulation of Orthosiphon 
stamineus loaded nanostructured lipid carrier to enhance penetration through the skin 
and induced lipolysis in adipocyte 
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1.4 Scope of the Research 
 
 
 In order to achieve the objective of this study, the following scopes have been 
identified as below: 
 
 
1. Extraction of OS using maceration method. 
2. Formulation of OS-NLC using melt emulsification homogenization technique. 
3. Optimization of OS-NLC using D-optimal mixture design by design expert 
software. 
4. Characterization of optimized formulation of OS-NLC using Transmission 
Electron Microscopy (TEM), Differential Scanning Calorimetry (DSC), Fourier 
Transform Infrared Spectroscopy (FTIR) 
5. In vitro penetration study by Franz type diffusion cell 
6. In vitro cytotoxicity study of OS-NLC on 3T3-L1 preadipocyte using MTT assay 
7. Investigation on lipolysis induction of OS-NLC on 3T3-L1 adipocytes 
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